Abstract
Acute and chronic kidney diseases (AKI and CKD) are frequently seen in non-renal solid organ transplant (NR-SOT) recipients. Assessing kidney function in this population remains a challenge as estimates of GFR are based on serum creatinine, which can be falsely low in these patients due to sarcopenia. Using CKD-EPI cystatin-C based equation to assess eGFR can mitigate this problem, but it is not always used due to lack of availability and costs. In addition to calcineurin inhibitor use, numerous peri-transplant factors also contribute to the development of AKI and CKD among NR-SOT recipients. Renoprotective strategies and management of CKD and its complications among NR-SOT recipients should follow general expert guidelines. Among liver transplant candidates, guidelines exist for simultaneaous liver-kidney transplant and rescue kidney transplant for those who undergo liver transplant alone. At the time of writing, no guidelines exist for combined heart-kidney transplant. A multidisciplinary approach with open communication between transplant teams and a nephrologist is imperative to the care of NR-SOT recipients with kidney dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Transplant trends. UNOS. Accessed 3 Dec 2019. https://unos.org/data/transplant-trends/.
Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation. 2004;78(9):1351–5. https://doi.org/10.1097/01.tp.0000140848.05002.b8.
Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(26):2563–5. https://doi.org/10.1056/nejm200312253492617.
Kidney Disease: Improving Global Outcomes (KDIGO). Clinical practice guideline for the evaluation and management of the chronic kidney disease (CKD). 2012. https://kdigo.org/guidelines/ckd-evaluation-and-management/.
Feehally J. Comprehensive clinical nephrology. Edinburgh: Elsevier; 2019.
Broekroelofs J, Stegeman C, Navis G, Haan JD, Bij WVD, Boer WD, de Zeeuw D, Jong PD. Creatinine-based estimation of rate of long-term renal function loss in lung transplant recipients. Which method is preferable? J Heart Lung Transplant. 2000;19(3):256–62. https://doi.org/10.1016/s1053-2498(99)00133-3.
Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10(2):301–9. https://doi.org/10.1002/lt.20017.
Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol. 2007;18(12):3031–41. https://doi.org/10.1681/asn.2007040394.
Ishani A, Erturk S, Hertz MI, Matas AJ, Savik K, Rosenberg ME. Predictors of renal function following lung or heart-lung transplantation. Kidney Int. 2002;61(6):2228–34. https://doi.org/10.1046/j.1523-1755.2002.00361.x.
Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol. 1991;2(Suppl):S45–52.
O’Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 2006;21:2630–6.
Platz K-P, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Nephrotoxicity following orthotopic liver transplantation: a comparison between cy- closporine and FK506. Transplantation. 1994;58:170–8.
Mccauley J, Thiel DHV, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121–8. https://doi.org/10.1159/000185938.
Srinivas TR, Stephany BR, Budev M, Mason DP, Starling RC, Miller C, Goldfarb DA, Flechner SM, Poggio ED, Schold JD. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol. 2010;5(10):1881–6. https://doi.org/10.2215/cjn.02950410.
Guitard J, Ribes D, Kamar N, Cointault O, Lavayssiere L, Esposito L, Rostaing L, Muscari F, Suc B, Peron JM. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail. 2006;28:419–25.
Canales M, Youssef P, Spong R, Ishani A, Savik K, Hertz M, Ibrahim HN. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant. 2006;6:2157–63.
Freedman BI, Moxey-Mims M. The APOL1 long-term kidney transplantation outcomes network—APOLLO. Clin J Am Soc Nephrol. 2018;13(6):940–2. https://doi.org/10.2215/cjn.01510218.
Bloom R, Doyle A. Kidney disease after heart and lung transplantation. Am J Transplant. 2006;6(4):671–9. https://doi.org/10.1111/j.1600-6143.2006.01248.x.
Nadkarni GN, Chauhan K, Patel A, Saha A, Poojary P, Kamat S, Patel S, Ferrandino R, Konstantinidis I, Garimella PS, Menon MC, Thakar CV. Temporal trends of dialysis requiring acute kidney injury after orthotopic cardiac and liver transplant hospitalizations. BMC Nephrol. 2017;18(1) https://doi.org/10.1186/s12882-017-0657-8.
Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993;43(3):706–11. https://doi.org/10.1038/ki.1993.101.
Thomas LD, Vilchez RA, White ZS, Zanwar P, Milstone AP, Butel JS, Dummer S. A prospective longitudinal study of polyomavirus shedding in lung transplant recipients. J Infect Dis. 2007;195:442–9.
Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, Weck K. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol. 2005;77:238–43.
Muñoz P, Fogeda M, Bouza E, Verde E, Palomo J, Bañares R. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis. 2005;41(12):1720–5. https://doi.org/10.1086/498118.
Pham P-T, Pham P-M, Pham P-C. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011:175. https://doi.org/10.2147/dmso.s19027.
Hjelmesth J, Hartmann A, Kofstad J, Stenstrm J, Leivestad T, Egeland T, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age 1. Transplantation. 1997;64(7):979–83. https://doi.org/10.1097/00007890-199710150-00008.
Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol. 2008;3(Supplement 2) https://doi.org/10.2215/cjn.02650707.
Drachenberg CB, Klassen DK, Wiland A, Weir MR, Fink JC, Cangro CB, Blahut S, Papadimitriou JC. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation. 1999;67(7) https://doi.org/10.1097/00007890-199904150-00834.
Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and vascular surgery–associated acute kidney injury: the 20th international consensus conference of the ADQI (Acute Disease Quality Initiative) group. J Am Heart Assoc. 2018;7(11) https://doi.org/10.1161/jaha.118.008834.
Rocha PN, Rocha AT, Palmer SM, Davis RD, Smith SR. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant. 2005;5(6):1469–76. https://doi.org/10.1111/j.1600-6143.2005.00867.x.
Lin J, Valeri AM, Markowitz GS, Dagati VD, Cohen DJ, Radhakrishnan J. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation. 2002;73(5):783–8. https://doi.org/10.1097/00007890-200203150-00022.
Artz MA. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transpl. 2004;19(11):2852–7. https://doi.org/10.1093/ndt/gfh462.
Gogia A, Kakar A, Gangwani A. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. Curr Med Res Pract. 2019;9(4):164. https://doi.org/10.1016/j.cmrp.2019.07.012.
Cassuto JR, Reese PP, Sonnad S, Bloom RD, Levine MH, Olthoff KM, Shaked A, Abt P. Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant. 2010;10(11):2502–11. https://doi.org/10.1111/j.1600-6143.2010.03292.x.
Simultaneous Liver-Kidney Allocation (SLK) policy changes now in effect. UNOS, June 6, 2019. https://unos.org/news/simultaneous-liver-kidney-allocation-slk-policy-changes-now-in-effect/.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mejia, C., Yadav, A. (2022). Chronic Kidney Disease in Non-renal Solid Organ Transplantation. In: McCauley, J., Hamrahian, S.M., Maarouf, O.H. (eds) Approaches to Chronic Kidney Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-83082-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-83082-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-83081-6
Online ISBN: 978-3-030-83082-3
eBook Packages: MedicineMedicine (R0)